cjc-1295 ipamorelin synergistic gh igf-1 + CJC-1295, Ipamorelin, Tesamorelin & Sermorelin:

Tay Sachs disease (GM2 Ganglioside) using targeted enzyme replacement therapy with alpha-hexosaminidase A or substrate inhibition of glucosylceramide synthase using imino sugars (e.g., miglustat (Zavesca marketed by Actelion) = N-butyl-deoxynojirimycin (NB-DNJ))

Montrose DC, Nishiguchi R, Basu S, Staab HA, Zhou XK, Wang H, et al

Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota

5 Synergistic Bioactives: L-Glutathione, Collagen Builder, Hyaluronic Acid, Astaxanthin, and Lycopene work together for optimal results

The converse is also true, as blocking TCA entry of either carbohydrates or fats decreases NADPH and GSH, makes the ER more oxidizing, and diminishes ER stressan effect that can be phenocopied by inhibiting GR (Gansemer et al., 2020)